logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9579295 B1

PDFFull Text
Date of Patent:
Feb. 28, 2017

Filed:

Jul. 20, 2015

Dosage form for insertion into the mouth

Applicant:

Nal Pharmaceutical Group Limited, Causeway Bay, HK;

Inventors:

Je Phil Ryoo, Princeton, NJ (US);

Chun Kwong Chu, Shatin, HK;

Zheng Wang, Bridgewater, NJ (US);

Assignee:

NAL PHARMACEUTICAL GROUP LIMITED, Causeway Bay, HK;

Attorney:

Lucas & Mercanti, LLP

Primary Examiner:

Robert A Wax

Assistant Examiner:

Melissa Mercier

Int. Cl.
CPC ...
A61K 9/70 (2006.01); A61K 38/06 (2006.01); A61K 9/00 (2006.01); A61K 31/00 (2006.01); A61K 31/4196 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 9/20 (2006.01); A61K 31/192 (2006.01); A61K 31/4045 (2006.01); A61K 31/422 (2006.01); A61K 31/4439 (2006.01); A61K 31/445 (2006.01); A61K 31/495 (2006.01); A61K 31/55 (2006.01); A61K 38/05 (2006.01); A61K 31/465 (2006.01); A61K 31/78 (2006.01); A61K 31/196 (2006.01); A61K 31/421 (2006.01); A61K 31/4468 (2006.01);
U.S. Cl.
CPC ...
A61K 9/7015 (2013.01); A61K 9/006 (2013.01); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/7007 (2013.01); A61K 31/00 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/4045 (2013.01); A61K 31/4196 (2013.01); A61K 31/421 (2013.01); A61K 31/422 (2013.01); A61K 31/445 (2013.01); A61K 31/4439 (2013.01); A61K 31/4468 (2013.01); A61K 31/465 (2013.01); A61K 31/495 (2013.01); A61K 31/55 (2013.01); A61K 31/78 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01);
Abstract

Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.

Find Patent Forward Citations

Loading…